Skip to main content
SpringerLink
Log in

Response to Letter to the Editor Re: “EUS-Guided Intragastric Injection of Botulinum Toxin A in the Preoperative Treatment of Super-Obese Patients: a Randomized Clinical Trial”

  • Letter to Editor/LED Reply
  • Published:
Obesity Surgery Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. de Moura EGH, Ribeiro IB, Frazão MSV, et al. EUS-guided intragastric injection of botulinum toxin A in the preoperative treatment of super-obese patients: a randomized clinical trial. Obes Surg [Internet]. 2018; Available from: http://link.springer.com/10.1007/s11695-018-3470-y. Accessed 07/12/2018

  2. Jirapinyo P, Thompson CC. Endoscopic bariatric and metabolic therapies: surgical analogues and mechanisms of action. Clin Gastroenterol Hepatol. 2017;15(5):619–30.

    Article  PubMed  Google Scholar 

  3. Moura D, Oliveira J, De Moura EG, et al. Effectiveness of intragastric balloon for obesity: a systematic review and meta-analysis based on randomized control trials. Surg Obes Relat Dis. 2016;12(2):420–9.

  4. Gui D, Mingrone G, Valenza V, et al. Effect of botulinum toxin antral injection on gastric emptying and weight reduction in obese patients: a pilot study. Aliment Pharmacol Ther. 2006;23:675–80.

  5. Mittermair R, Keller C, Geibel J. Intragastric injection of botulinum toxin A for the treatment of obesity. Obes Surg. 2007;17:732–6. Surg [Internet]. 2006;16:335–43. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16545166. Accessed 07/12/2018

  6. Foschi D, Corsi F, Lazzaroni M, et al. Treatment of morbid obesity by intraparietogastric administration of botulinum toxin: a randomized, double-blind, controlled study. Int J Obes [Internet]. 2007;31:707–12. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17006442. Accessed 07/12/2018

  7. Rhee P-L, Lee JY, Son HJ, et al. Analysis of pacemaker activity in the human stomach. J Physiol [Internet]. 2011;589:6105–18. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22005683. Accessed 07/12/2018

  8. Yun H-Y, Sung R, Kim YC, et al. Regional distribution of interstitial cells of Cajal (ICC) in human stomach. Korean J Physiol Pharmacol [Internet]. 2010;14:317–24. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21165331. Accessed 07/12/2018

  9. Albanese A, Bentivoglio AR, Cassetta E, et al. Review article the use of botulinum toxin in the alimentary tract. Aliment Pharmacol Ther. 1995;9:599–604.

  10. Xing J, Chen JDZ. Alterations of gastrointestinal motility in obesity. Obes Res. 2004;12:1723–32.

    Article  PubMed  Google Scholar 

  11. Bustamante F, Brunaldi VO, Bernardo WM, et al. Obesity treatment with botulinum toxin-A is not effective: a systematic review and meta-analysis. Obes Surg. 2017;27:2716–23.

Download references

Author information

Authors and Affiliations

  1. Gastrointestinal Endoscopy Unit, Hospital das Clínicas, School of Medicine, University of Sao Paulo, São Paulo, Brazil

    Igor Braga Ribeiro, Diogo Turiani Hourneaux de Moura & Eduardo Guimarães Hourneaux de Moura

  2. Instituto Central, Av. Dr. Enéas de Carvalho Aguiar, 255, Prédio dos Ambulatórios, Pinheiros, São Paulo, SP, 05403-000, Brazil

    Igor Braga Ribeiro

Authors
  1. Igor Braga Ribeiro
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Diogo Turiani Hourneaux de Moura
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Eduardo Guimarães Hourneaux de Moura
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

IBR, DTHdM, and EGHdM wrote the response letter and approved the final draft of this manuscript.

Corresponding author

Correspondence to Igor Braga Ribeiro.

Ethics declarations

Conflict of Interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ribeiro, I.B., de Moura, D.T.H. & de Moura, E.G.H. Response to Letter to the Editor Re: “EUS-Guided Intragastric Injection of Botulinum Toxin A in the Preoperative Treatment of Super-Obese Patients: a Randomized Clinical Trial”. OBES SURG 29, 1016–1017 (2019). https://doi.org/10.1007/s11695-018-03665-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11695-018-03665-8

Search

Navigation